Alnylam Pharmaceuticals, Inc.

Report date
12/31/2025
Quarter
2025 Q4
Filed
2/3/2026
Shares
38,864
Value ($000)
15,454
Weight
1.6%
2025 Q3 - 2025 Q4 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).